PRECLINICAL AND CLINICAL-STUDIES ON THE CARDIOVASCULAR AND RENAL EFFECTS OF FENOLDOPAM - A DA-1 RECEPTOR AGONIST

被引：36

作者：

LOKHANDWALA, MF

机构：

来源：

DRUG DEVELOPMENT RESEARCH | 1987年 / 10卷 / 03期

关键词：

D O I：

10.1002/ddr.430100302

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：123 / 134

页数：12

共 55 条

[1]

ACKERMAN DM, 1983, FED PROC, V42, P186

[2] RENAL VASODILATORS AND HYPERTENSION [J].

ACKERMAN, DM ;

WEINSTOCK, J ;

WIEBELHAUS, VD ;

BERKOWITZ, B .

DRUG DEVELOPMENT RESEARCH, 1982, 2 (03) :283-297

[3]

ACKERMAN DM, 1983, FED PROC, V42, P748

[4]

ALKADHI KA, 1986, J PHARMACOL EXP THER, V238, P547

[5] DOPAMINE DECREASES FLUID REABSORPTION IN STRAIGHT PORTIONS OF RABBIT PROXIMAL TUBULE [J].

BELLOREUSS, E ;

HIGASHI, Y ;

KANEDA, Y .

AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 242 (06) :F634-F640

[6]

BRENNAN F, 1983, FED PROC, V42, P1133

[7] SELECTIVE PERIPHERAL DOPAMINE-1 RECEPTOR STIMULATION WITH FENOLDOPAM IN HUMAN ESSENTIAL-HYPERTENSION [J].

CAREY, RM ;

STOTE, RM ;

DUBB, JW ;

TOWNSEND, LH ;

ROSE, CE ;

KAISER, DL .

JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06) :2198-2207

[8] DOPAMINE SELECTIVELY INHIBITS ALDOSTERONE RESPONSES TO ANGIOTENSIN-II IN HUMANS [J].

CAREY, RM ;

DRAKE, CR .

HYPERTENSION, 1986, 8 (05) :399-406

[9] EFFECTS OF METOCLOPRAMIDE AND BROMOCRIPTINE ON THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN MAN - DOPAMINERGIC CONTROL OF ALDOSTERONE [J].

CAREY, RM ;

THORNER, MO ;

ORTT, EM .

JOURNAL OF CLINICAL INVESTIGATION, 1979, 63 (04) :727-735

[10] DOPAMINERGIC INHIBITION OF METOCLOPRAMIDE-INDUCED ALDOSTERONE SECRETION IN MAN - DISSOCIATION OF RESPONSES TO DOPAMINE AND BROMOCRIPTINE [J].

CAREY, RM ;

THORNER, MO ;

ORTT, EM .

JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (01) :10-18

← 1 2 3 4 5 6 →